CervoMed Inc.CRVONASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+153.7%
5Y CAGR+18.3%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+153.7%/yr
vs -30.6%/yr prior
5Y CAGR
+18.3%/yr
Recent acceleration
Acceleration
+184.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$21.82M+16.1%
2024$18.80M+122.8%
2023$8.44M+531.4%
2022$1.34M-84.3%
2021$8.50M-9.8%
2020$9.43M+42.4%
2019$6.62M+15.1%
2018$5.75M+13.0%
2017$5.09M-18.6%
2016$6.25M-